Neogen Corporation (NEOG:NASDAQ) closed at $12.27 on October 15, 2026, up 1.15% on the day. The stock trades 14.0% below its 52-week high of $14.26 and 128.5% above its 52-week low of $5.37. Over the past year, it gained 106.9%. Neogen Corporation is part of the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +2.25% | -2.23% | +22.58% | +27.41% | +106.91% |
In 252 trading sessions since October 15, 2025, NEOG closed higher on 140 days (56%). Its best day was January 8, 2026 (+31.57%) and its worst was March 6, 2026 (-9.26%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products and services for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug and pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, and dairies; laboratories; producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various regulatory agencies. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services...
Find more stocks like NEOG with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.